Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study.
<h4>Background</h4>Hyperuricemia is highly prevalent in chronic kidney disease (CKD) patients, but the evidence for a relationship between uric acid (UA) and clinical outcomes in CKD patients is limited and inconsistent. We hypothesized that UA has a different impact on clinical outcomes...
Guardado en:
Autores principales: | Kimio Watanabe, Masaaki Nakayama, Tae Yamamoto, Gen Yamada, Hiroshi Sato, Mariko Miyazaki, Sadayoshi Ito |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2633d03062a348a58fc9c181bdb4aac2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Yousuf Waheed, et al.
Publicado: (2021) -
HYPERURICEMIA IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS. A SINGLE CENTRE EXPERIENCE
por: Mohsin Qayyum, et al.
Publicado: (2019) -
Enhanced neutrophil apoptosis accompanying myeloperoxidase release during hemodialysis
por: Taro Fukushi, et al.
Publicado: (2020) -
Waist to height ratio is an independent predictor for the incidence of chronic kidney disease.
por: Keiichi Odagiri, et al.
Publicado: (2014) -
Novel haemodialysis (HD) treatment employing molecular hydrogen (H2)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study
por: Masaaki Nakayama, et al.
Publicado: (2018)